Skip to main content

Press Release

Press Release: Clean Syringe Funding Ban for DC Lifted!

FOR IMMEDIATE RELEASE: June 5, 2007 CONTACT: Naomi Long, (202) 669-6071 or Bill Piper, (202) 669-6430 Clean Syringe Funding Ban for District of Colombia Lifted Rep. Serrano Removes Provision Prohibiting Tax Payer Money Going to D.C. Syringe Exchange Programs Today Congress moved to lift the funding ban on syringe exchange programs in Washington, DC. The House Subcommittee on Financial Services and General Government removed the ban from an appropriations bill that includes the city’s spending plan. In 1998, the Republican-led Congress barred the District Government from spending its own local funds on syringe exchange programs. The ban has been reauthorized in the appropriations bill every year since. But with Democrats now in power, the push to lift the ban gained traction. Rep. Jose Serrano (D-NY), who chairs the committee, spearheaded the effort to lift the ban. “This is a huge step in helping to reduce HIV and AIDS in Washington, DC,” said Naomi Long, director of the Washington Metro office for the Drug Policy Alliance. “We are pleased that Congress decided to stop playing politics with the lives of intravenous drug users in D.C.” It has been long established by the scientific community that needle exchange programs reduce the spread of HIV/AIDS amongst people who inject drugs without increasing drug use. In Washington, DC, injecting drugs is the second-most common means of contracting HIV among men - and the most common form among women. Approximately one-third of new AIDS cases annually are the result of intravenous drug use. Supporters of needle exchange include the American Medical Association, American Public Health Association, Centers for Disease Control and three former U.S. Surgeons General. A number of faith communities officially support needle exchange including The Presbyterian Church (USA), Episcopal Church and the United Church of Christ.

Press Release: California to Fund Needle Exchange Programs for the First Time

For Immediate Release: June 4, 2007 California to Fund Needle Exchange Programs for the First Time, Governor Passage of Legislation Still Needed to Purchase Syringes SACRAMENTO -- For the first time, the state of California will fund some needle exchange programs. On June 1, the HIV Education and Prevention Services Branch of the Office of AIDS announced awards totaling $2.25 million of direct state funding to Syringe Exchange Programs (SEPs). Ten syringe exchange programs were awarded for $75,000 a year each for three years. Community-based organizations that operate SEPs and local health jurisdictions in areas where SEPs are approved for operation were awarded the grants. Because of a California law that denies the use of state funds to purchase syringes themselves, this funding will be dedicated to improving access to sterile syringes by increasing SEP operating hours, purchasing non-syringe operating materials, expanding syringe exchange to new locations, adding staff or improving compensation for existing staff as well as adding outreach workers, to encouraging clients of SEPs to test for HIV and HCV and link clients to medical care when appropriate. Funds may also be used to add services, such as wound care, that improve overall health and wellness for injection drug users. Assemblymember John Laird is sponsoring a bill, AB 110, to change the state law that denies the use of state HIV prevention funds for the purchase of syringes for clean needle and syringe exchange projects. The same bill was passed by a strong majority in the California legislature last year, but was pulled when Governor Schwarzenegger threatened a veto. Proponents are hopeful that this funding from the Office of AIDS will demonstrate the need for state commitment to such programs. "This funding represents a positive sea change in terms of support for needle exchange in California, said Hilary McQuie of the Harm Reduction Coalition, "But there are over 30 other programs in CA that don't get any state funding and survive on a shoestring, while courageously serving as a bridge between active injection drug users and medical and social services, reducing the spread of HIV and other blood borne diseases, and reducing the number of syringes discarded in public places. The governor should follow the lead of the Office of AIDS, and let local communities use their prevention dollars as they see fit." According to the Center for Disease Control, over a third of adult AIDS cases are associated directly or indirectly with injection drug use. In California, sharing contaminated injection equipment accounts for 20 percent of new AIDS cases. State data also suggests that more than 1500 new HIV infections occur annually due to syringe sharing. Seventy-five percent of HIV infections among women and children are related to sharing of injection equipment, and communities of color are hit especially hard. In addition to the human toll, the cost of medical treatment ranges from $200,000 to $600,000 over the lifetime of one HIV patient. # # # # The Harm Reduction Coalition is a national advocacy and capacity-building organization that promotes the health and dignity of individuals and communities impacted by drug use. For more information, see www.harmreduction.org

Press Release: CT Set to Become 13th State to Legalize Use of Medical Marijuana

FOR IMMEDIATE RELEASE: June 4, 2007 CONTACT: Lorenzo Jones (860) 270-9586 or Gabriel Sayegh (646) 335-2264 Connecticut Set to Become 13th State to Legalize Use of Medical Marijuana Compassionate Use Bill Passes Legislature by Wide Margins, Heads to Governor’s Desk Patients, Doctors, Caregivers Call Upon Gov. Rell to Have Compassion, Support Patients by Signing HB 6715 HARTFORD, CT—Connecticut is on the verge of becoming the thirteenth state to allow the use of medical marijuana. The Connecticut State Senate passed HB 6715, the Compassionate Use Act late last Friday. The bill passed by a 23-13 margin after clearing the House of Representatives by an 89-58 margin weeks earlier. The bill now goes to Gov. M. Jodi Rell for her signature. If Rell neither signs nor vetoes the bill, it will automatically become law. Thousands of Connecticut residents live with crippling pain, are suffering with cancer and HIV/AIDS, or other debilitating ailments. HB 6715 allows Connecticut residents with certain debilitating medical conditions to cultivate and use marijuana for medical purposes when recommended by a practicing physician. “This bill will help alleviate the feelings of helplessness that families face when their loved ones suffer,” said Lorenzo Jones, executive director of A Better Way Foundation. “We’ve believed all along that compassion and fairness would bring this bill to final passage. Now we need the Governor to sign the bill so families and patients can have some relief. We know she’ll do the right thing.” By passing HB 6715, the Legislature ended a five-year Legislative battle to win medical marijuana in a state that has overwhelming public support for the issue. A 2004 University of Connecticut poll found that 84 percent of Connecticut residents support the medical use of marijuana. Dozens of community organizations, including the CT Nurses Association, support medical marijuana. “Allowing for the use of marijuana for medicinal purposes is the right thing to do for the State of Connecticut,” said bill sponsor, Rep. Penny Bacchiochi, R-District 52. “This issue is not about legalizing drugs. It's about keeping those who seek compassionate care for treating crippling diseases out of jail.” Currently, there are 12 states with medical marijuana laws. New Mexico passed its medical marijuana bill in March. Last month, the Rhode Island legislature voted to make their state law permanent, and last week Vermont’s legislature voted to expand their medical marijuana law. Other medical marijuana bills are currently under consideration in New Jersey, New York and Alabama. “I am just 32 years old and yet due to my medical condition I feel as if, at times, I am 92,” said Joshua Warren, a patient in Wilton, CT, who suffers from chronic neurological Lyme disease. “I did not ask for this condition nor would I wish any of my pain and other symptoms on anyone else. I hope Gov. Rell will have compassion for me and for others and signs this bill.” ###

Press Release: OD Prevention Bill Receives Unanimous Senate Support

For Immediate Release: June 1, 2007 Media Contact: Hilary McQuie 510-333-8554 Overdose Bill Receives Unanimous California Senate Support SACRAMENTO - California Senate Bill (SB) 767, the Overdose Treatment Liability Act, cosponsored by the Harm Reduction Coalition (HRC), a national health and human rights advocacy group working to reduce drug-related harm, the County of Los Angeles, and the Los Angeles Overdose Taskforce, passed the bipartisan California Senate yesterday in a unanimous vote. Thanks to the leadership of Senator Mark Ridley-Thomas, the author of SB 767, California legislators are beginning to recognize the importance of access to naloxone, a very safe drug that lay people, with appropriate training, can safely and properly administer. SB 767 will make it easier for health care professionals to participate in comprehensive drug overdose prevention programs that prescribe the opioid antagonist naloxone, thereby removing a large obstacle to the creation and expansion of such programs in California. This proposed legislation will also make it easier to get naloxone into the hands of the people who are the most likely to be bystanders to opioid overdoses, increasing the likelihood that people overdosing on opioids will receive naloxone promptly. When the Senate Judiciary Committee heard the bill early last month, Sandi McClure, a member of the Los Angeles Overdose Taskforce, delivered powerful testimony about the loss of her daughter, Jennifer, 15 months ago to a heroin overdose. Ms. McClure noted that if her daughter or her friends had access to naloxone and knew how to respond to an overdose, Jennifer might still be alive today. Drug overdose, which is entirely preventable, is the second leading cause of accidental death in the United States. When a person overdoses on opioids (heroin, morphine, methadone, oxycontin, etc.), he/she is rendered unconscious and is in danger of dying because the opioids slow down, and eventually stop, the person's breathing. Naloxone counteracts life-threatening depression of the central nervous and respiratory systems caused by an opioid overdose, allowing an overdose victim to breathe normally. Currently, naloxone can be prescribed only by licensed health care professionals, and has the same level of regulation as prescription ibuprofen. SB 767 protects providers who prescribe take-home naloxone, facilitating greater access to lifesaving medicine for people experiencing opioid overdoses. The Assembly Judiciary Committee will hear the bill later this month. # # # # For more information about the Harm Reduction Coalition, visit http://www.harmreduction.org/.

Press Release: Local Non-Profit Group Seeking to End Racist Drug Laws, Town Hall Meeting Set to Discuss Federal Law Reform, Activists & Politicians

For Immediate Release: May 31, 2007 Contact: Rev. Kenneth Glasgow, E: [email protected], Tel: 334-685-7377 Local Non-Profit Group Seeking to End Racist Drug Laws Town Hall Meeting Set to Discuss Federal Law Reform, Activists & Politicians Birmingham - On June 2, 2007, The Ordinary People’s Society (TOPS) will co-sponsor a town hall meeting that will be hosted by the American Civil Liberties Union (ACLU) in Birmingham, Alabama on the need to repair the current discriminatory federal drug sentencing policy. The event is open to the press, and TOPS speakers will be available before and afterwards for interviews. What: The Incarceration Nation – Town Hall Meeting on Crack vs. Powder Cocaine Sentencing Disparities Speakers: Congressman Artur Davis, (D - Birmingham) Senator Jeff Sessions (R - AL) (invited) Rev. Kenneth Glasgow, Executive Director of TOPS Ed Vaughan, President, Alabama State Conference NAACP Dr. Foster Cook, Director, UAB - Treatment Alternatives for Safer Communities Deborah Vagins, Policy Council for Civil Rights, ACLU Washington Legislative Office Barry Hargrove, Field Organizer, ACLU Washington Legislative Office When: 9:00am - 1:00pm Saturday, June 2 Where: Church of the Reconciler - 112 14th Street, North - Birmingham, AL Currently, distributing just five grams of crack carries a minimum five-year federal prison sentence, while distributing 500 grams of powder cocaine carries the same sentence. Despite repeated recommendations by the U.S. Sentencing Commission, Congress has not addressed this 100:1 sentencing disparity, which has devastated African-American communities and undermined faith in the criminal justice system. African-Americans comprise the vast majority of those convicted of crack cocaine offenses, although whites and Hispanics form the majority of crack users. “These laws highlight the indecent and subconscious racist tactics still supported in the criminal justice system,” said Kenneth Glasgow, Executive Director of The Ordinary People’s Society. “Five grams of crack cocaine sets forth a mandatory minimum of five years in prison, yet five-hundred grams of powder cocaine” A 2006 ACLU report found no medical or legal justification for the unfair sentencing disparity ratio. Although Congress' stated intent was to target high-level cocaine traffickers, the result has been just the opposite - a 2002 USSC report found that only 15 percent of federal cocaine traffickers can be classified as high-level, while over 70 percent of crack defendants have low-level involvement in drug activity, such as street level dealers, couriers, or lookouts. T.O.P.S. is a nonprofit, faith-based organization that offers hope, without regard to race sex, creed, color or social status, to individuals and their families who suffer the effects of drug addiction, incarceration, homelessness, unemployment, hunger and illness, through comprehensive faith-based programs that provide a continuum of unconditional acceptance and care. ### T.O.P.S. (The Ordinary People Society) are a nonprofit organization that will provide an alternative to criminal behavior. This is a faith-based organization that will bridge the gap between the have and have-nots. We will provide rehabilitation to the repeat offenders while creating a program that target the youths before they reach the Criminal Justice System. Since the War on Drugs has been established the prison populations have continued to increase costing taxpayers more than $20,000 per inmate. This method is draining many State Governments. Also, families are suffering due to the lost of a mother, father, sister or brother. With our counseling and street ministry we are providing a second chance for many of our citizens both drug users and drug pushers. We would like to extend our program to include an after school program for youths and also for some adults so they can take pride and improve their self-esteem while improving their own family's life. T.O.P.S. provides counseling services to Ramsey Youth Services, Houston County Jail, and Dothan City Jail. T.O.P.S. would like to include a transitional facility that will provide a structural environment that will include education, treatment, and rehabilitation.

Medical marijuana group moves to hasten outcome in federal lawsuit

For immediate release: May 24, 2007 Contact: ASA Legal Campaign Director Kris Hermes at 510-251-1856 x307 or ASA Chief Counsel Joe Elford at 415-573-7842 Medical marijuana group moves to hasten outcome in federal lawsuit Patients file motion for summary judgment today to correct government misinformation San Francisco, CA – A national medical marijuana patients’ rights group filed a motion for summary judgment today in its lawsuit against the federal government in an attempt to accelerate a decision in the case. The plaintiff, Americans for Safe Access (ASA), filed a lawsuit in February 2007 challenging statements by the federal Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) that marijuana has no accepted medical value. The lawsuit followed a two-year administrative petition process using a little-known law called the Data Quality Act (DQA), which allows parties to challenge the science used in regulatory policy. By filing the motion for summary judgment, ASA will force the case to be heard in roughly 90 days. This rare legal move, where judgment is requested from the court before the government has a chance to answer the lawsuit complaint, indicates confidence in the amount of scientific evidence demonstrating marijuana’s medical efficacy. “We are taking an aggressive legal approach for two reasons,” said ASA Chief Counsel Joe Elford. “Not only do we believe we have science on our side, but by quickening the pace with which the federal government recognizes that science,, seriously ill persons who might benefit from medical marijuana will no longer be discouraged from using it.” The exhibits filed in support of the motion for summary judgment include more than a dozen domestic and international peer-reviewed scientific studies that show the effectiveness of marijuana in treating pain, nausea, muscle spasticity, and many other conditions. The evidence provided by ASA is meant to refute claims by the federal government that “there have been no studies that have scientifically assessed the efficacy of marijuana for any medical condition.” (66 Fed.Reg. 20038, 20052; April 18, 2001.) In addition to the overwhelming evidence, a lack of disputed facts will also help to secure a speedy decision by the court. The plaintiff’s case was affirmed by a recent editorial in Science Magazine, a publication of the American Association for the Advancement of Science, which posited that HHS had “violated its own DQA guidelines.” The Science editorial followed a February publication by the peer-reviewed journal Neurology of a human trials study in the U.S. clearly showing that marijuana relieved neuropathic pain in people living with HIV/AIDS. If successful, ASA’s case will be the first in which a court has recognized the necessity of reviewing disputes filed under the DQA. Two other courts have already denied review in lawsuits filed under the Act by large corporations. Review the Motion for Summary Judgment at http://www.safeaccessnow.org/downloads/DQA_Summary_Judgment_Motion.pdf. Review info on the Data Quality Act and ASA’s lawsuit against the federal government at http://www.safeaccessnow.org/article.php?list=type&type=160. # # # With over 30,000 active members in more than 40 states, Americans for Safe Access (ASA) is the largest national member-based organization of patients, medical professionals, scientists and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research. ASA works to overcome political and legal barriers by creating policies that improve access to medical cannabis for patients and researchers through legislation, education, litigation, grassroots actions, advocacy and services for patients and the caregivers.

NAMA Press Release: Leaders of NAMA’s Swedish Affiliate Svenska Brukarforeningen (SBF) Report to Police for Handing Out Clean Needles

National Alliance of Methadone Advocates For Immediate Release: May 17, 2007 Contact Person: Joycelyn Woods, President, Tel: 212-595-NAMA, E: [email protected] Leaders of NAMA’s Swedish Affiliate Svenska Brukarforeningen (SBF) Report to Police for Handing Out Clean Needles On May 4 SBF’s President, Berne StÃ¥lenkrantz and the Stockhom Director, Johan Stenbäck presented themselves to the Norrmalm Police Station in Stockholm for handing out clean needles to drug users. The purpose of the action was to get an official assessment of the their crime and to bring to the public the fact that Sweden does not allow syringes to be sold in pharmacies as is done is all other countries in the European Union (EU). SBF is also considering reporting Sweden to the European Union for its failure to comply with EU rules surrounding the common market. In southern Sweden needle exchange programs have been keeping the spread of HCV nd HIV under control for the past 20 years. County and Town Councils have been allowed to establish needle exchange programmes if they so wish. However in Stockholm no such programs have been established. According to StÃ¥lenkrantz if the penalty is mild they will continue with what they are doing. However after SBF publicized that they were providing drug users with clean needles the organization suddenly found its financing from Stockholm City Council under threat. StÃ¥lenkrantz also reported that a colleague suffering from a Hepatitis C was planning to report the city's social services department to the police because he has contracted a deadly illness after being refused clean syringes. He will also state that he was a victim of SBF’s having received clean syringes from the organization.. Needle exchange programs have been used worldwide for the past twenty years and provides a way for drug users to avoid the risks of drug use as well as a way to access support services including treatment. "We are handing out syringes for purely humanitarian reasons. And we are forced to do so since society is not providing this type of healthcare," said StÃ¥lenkrantz.

DPA Press Release: US Sentencing Commission urges Congress to Reduce Crack/Powder Cocaine Sentencing Disparity

For Immediate Release: May 17, 2007 Contact: Jasmine L. Tyler at 202-294-8292 US Sentencing Commission urges Congress to Reduce Crack/Powder Cocaine Sentencing Disparity Experts to Brief Congress on Current Cocaine Policy and the Need for Reform Washington, DC—Criminal justice experts will hold briefings on the crack/powder cocaine sentencing disparity for Congressional staffers on Monday, May 21. They will discuss the United States Sentencing Commission’s (USSC) May 2007 Guideline Amendment and Report to Congress. Joining the panel will be Hilary Shelton from the NAACP, Pat Nolan from Prison Fellowship, and Lisa Rich from the USSC. These briefings will be moderated by Jessalyn McCurdy of the ACLU and Marc Mauer of The Sentencing Project. The briefing is co-sponsored by the Drug Policy Alliance. ********************************************************************* WHAT: Reforming Crack and Powder Cocaine Sentencing Briefing for Congressional staffers WHO: Members of Congress and staff, media, policy advocates, stakeholders, treatment providers, faith leaders When: Monday, May 21 House Briefing: 9 a.m. - B340 Rayburn House Office Building Senate Briefing: 2 p.m. - 485 Russell Senate Office Building ********************************************************************* Twenty years ago when the crack cocaine sentencing laws were first passed by Congress, the United States faced a panic about the alleged “crack epidemic” and operated under the impression that crack had inherent properties that made it infinitely more dangerous than powder cocaine. These reports, which served as the basis for the huge disparity, have since been found to be fundamentally flawed, rendering the 100-to-1 disparity arbitrary and capricious. Further, these laws have proven ineffective in reducing drug use or distribution and have instead exacerbated racial disparity and injustices in our criminal justice system. The USSC has taken the lead on eliminating the crack/powder sentencing disparity by amending the federal sentencing guidelines to lessen the punishment range for crack cocaine cases by approximately one to two years. The Commission also urged Congress to reform federal mandatory minimum sentences to reduce the statutory disparity. Currently, there is growing bipartisan support for reforming the crack/powder disparity. There are two house bills pending and a similar one before the Senate. # # #

DPA Press Release: Lawmakers, judges, and advocates rebuke Gov. O’Malley’s veto of sentencing reform bill

For Immediate Release: May 17, 2007 Contact: Naomi Long (202) 669-6071 or Laura Jones: (202) 425-4659 Lawmakers, judges, and advocates rebuke Gov. O’Malley’s veto of sentencing reform bill; O’Malley “clinging to the failed policies of the past” in a “lapse of leadership” Coalition vows to continue educating O’Malley, promoting treatment instead of prisons Annapolis—A coalition of advocates, law enforcement officials, drug treatment providers and policy experts today denounced Governor O’Malley’s veto of a bill that would have provided the possibility of parole for non-violent drug offenders. The sentencing reform bill, HB 992, was one of the only bills vetoed by O’Malley, despite its support from the legislature, the coalition, and the editorial pages of the Washington Post and Baltimore Sun. “The veto is a disappointing mistake,” said Justice Policy Institute executive director Jason Ziedenberg. “Instead of taking a baby step in the right direction towards treatment instead of prison, O’Malley is stubbornly clinging to the failed tough on crime policies of the past. The governor failed to show leadership and vision in this decision.” States across the country have taken steps to reform ineffective mandatory sentencing laws that remove discretion to consider the individual facts of the case. Newly-elected Massachusetts Governor Deval Patrick (D) recently called for wide ranging mandatory minimum sentencing reform. Newly-elected New York Governor Elliot Spitzer added language in his budget for a prison closure commission, and is considering a bill to further reform the state’s Rockefeller Drug Laws. Under the comparatively modest Maryland reform, individuals convicted of a 10-year sentence for a nonviolent drug reform would have been eligible for, but not guaranteed, parole. Individuals convicted of violent crimes would serve the full 10-year sentences. “Governor O’Malley has put Maryland out of step with other states that are moving in the direction of smarter, more effective sentencing policies,” said Naomi Long, Director of the Drug Policy Alliance District of Columbia Metropolitan Area project. “This veto was a lapse of leadership, and hurts Maryland’s efforts to implement the kinds of real reforms that would actually make a difference.” The state of Maryland spends millions of dollars each year incarcerating nonviolent drug offenders, the vast majority of whom would be better served by drug treatment options. A recent report by the Justice Policy Institute found that Maryland's sentencing laws disproportionately affect communities of color and may be the least effective, most expensive way to promote public safety. “The fight for more effective and fair sentencing policies isn’t over,” said Delegate Curtis Anderson (D-Baltimore), a sponsor of the legislation. “Maryland voters want more fair and effective sentencing policies. We will keep working with the Governor to implement those reforms.” The Partnership for Treatment, Not Incarceration supported HB 992, and is a consortium of organizations and individuals including members of faith communities, public health and drug treatment professionals, public defenders, judges, police and other law enforcement. For more information about bill, or to interview spokespeople who can respond, contact Naomi Long (202)669-6071. To learn more about sentencing reform work in Maryland, visit: www.justicepolicy.org and www.drugpolicy.org .

CMMNJ Press Release: Jim Miller to push wheelchair across New Jersey for Medical Marijuana

FOR IMMEDIATE RELEASE: May 16, 2007 For more info, contact: Ken @ (609) 394-2137 Jim Miller to push wheelchair across New Jersey for Medical Marijuana WHAT: Wheel chair march across New Jersey to dramatize plight of patients who are suffering needlessly due to legislature’s failure to pass medical marijuana bill (S 88 & A 933). WHO: Jim Miller, co-founder of the Coalition for Medical Marijuana--New Jersey, Inc., and Libertarian Party candidate for state senate from 10th District. Libertarian Party members, patients and friends will join Mr. Miller at the start of the march. WHEN: Sunday, May 20, 2007 at 12 noon (start) through Tuesday, May 22, 2007, 11 a.m to 1 p.m. rally in Trenton (finish). WHERE: March starts at Captain Hooks Bar, 1320 Boulevard, Seaside Heights, NJ, crosses Rt. 37 Bridge and stops for lunch at The Pier, 3430 Rt. 37 east, Toms River. March proceeds to Rt. 9 to Rt 33 to Trenton. Jim Miller, the co-founder of the Coalition for Medical Marijuana--New Jersey, Inc., (CMMNJ) will once again push his wife, Cheryl’s memorial wheelchair across the state of New Jersey starting Sunday, May 20, 2007 at 12 noon in order to call attention to patients who are suffering needlessly because they are denied access to medically recommended marijuana. Cheryl Miller, who died in 2003 from complications of Multiple Sclerosis, was a medical marijuana user and a tireless advocate for the right of patients to use this drug. “Cheryl Miller died without ever being able to use marijuana legally in New Jersey, despite the fact that marijuana eased her muscle spasms more effectively than any other drug and did so safely and with minimal side effects,” said Ken Wolski, RN, Executive Director of CMMNJ. See www.cherylheart.org for more details. Jim Miller is also this year’s Libertarian Party candidate for state senator from New Jersey’s 10th District. Libertarian Party members, patients, and friends will accompany Mr. Miller on the first leg of his march, from Captain Hooks Bar, located at 1320 Boulevard, Seaside Heights, across the Rt. 37 bridge to The Pier restaurant in Toms River, where they will stop for lunch. For more details of this year’s march, see: http://www.njlp.org. Mr. Miller said it has been 14 years since the last time he pushed his wife’s wheelchair across New Jersey, in May 1993. This year, Mr. Miller is expected to arrive in Trenton on Tuesday, May 22, 2007 at approximately 11 a.m. There will be a rally on the steps of the State House in Trenton when Mr. Miller arrives, until 1:00 p.m. The Coalition for Medical Marijuana--New Jersey, Inc. is a non-profit educational organization. CMMNJ has public meetings on the second Tuesday of every month at the Lawrence Township (Mercer County) Library, from 7:00 PM until 9:00 PM. All are welcome. Light refreshments are served. For more info, contact: Ken Wolski, RN, MPA, Executive Director Coalition for Medical Marijuana--New Jersey, Inc. 844 Spruce St., Trenton, NJ 08648 609.394.2137 www.cmmnj.org [email protected]